Sustained virological response to treatment in patients with chronic hepatitis C

JAMA

Volumn 309, Issue 14, 2013, Pages 1457-

  Maisonneuve, Patrick ^a   Bruno, Savino ^b  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^b FATEBENEFRATELLI HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON;

DRUG RESPONSE; GENOTYPE; HEPATITIS C; HUMAN; LETTER; LIVER CELL CARCINOMA; LIVER FIBROSIS; PRIORITY JOURNAL; SUSTAINED VIROLOGICAL RESPONSE; FEMALE; LIVER CIRRHOSIS; MALE; MORTALITY; NOTE; VIREMIA; VIROLOGY;

FEMALE; HEPATITIS C, CHRONIC; HUMANS; LIVER CIRRHOSIS; MALE; VIREMIA;

EID: 84875932265     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2013.2726     Document Type: Letter

References (2)

1. van der Meer AJ, Veldt BJ, Feld JJ, et al. Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis. JAMA. 2012;308(24):2584-2593.
2. Raimondi S, Bruno S, Mondelli MU, Maisonneuve P. Hepatitis C virus genotype 1b as a risk factor for hepatocellular carcinoma development: a meta-analysis. J Hepatol. 2009;50(6):1142-1154.